Distress, not low libido alone, defines HSDD, which requires a biopsychosocial evaluation, according to Holly N. Thomas, MD, MS.
|Poll|October 7, 2021
Poll: Are you seeing a rise in STI cases?
Author(s)Lindsey Carr, Editor
People are being diagnosed with chlamydia and gonorrhea at a higher rate than ever before, according to the Centers for Disease Control and Prevention (CDC).
Advertisement
The U.S. Preventive Services Task Force (USPSTF) recently reviewed the latest evidence on screening for chlamydia and gonorrhea and ultimately issued an update to their 2014 recommendation.
Are you seeing a rise in STI cases in your practice?
Advertisement
Related to this article
Cultural upbringing gives context to sexual dysfunction but does not make the diagnosis, according to Sameena Rahman, MD, FACOG.
Susan Reed, MD, on the need for menopause research funding, a clinical trials network, and studies in understudied groups and perimenopause.
Chrisandra Shufelt, MD, on why menopause is a window for cardiovascular prevention and the risk factors OB/GYNs should assess.
Matthew Nudy, MD, on estrogen's cardiovascular effects, risk assessment, and hormone therapy safety in younger menopausal women.
ACOG advises against GLP-1 receptor agonists in pregnancy and recommends considering discontinuation 1 to 2 months before conception.
Rhonda Voskuhl, MD, on a case series in which estriol and progesterone improved self-reported cognition in menopausal women at 12 months.
Joint guidance from the AHA, AAP, ACOG, and SMFM organizes cardiovascular prevention for girls and women around 4 female life stages.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
ACOG advises against GLP-1 receptor agonists during pregnancy
2
Safety Monitoring and Dosing for NK3 Antagonists in Menopause VMS
3
Matthew Nudy, MD, on estrogen and the cardiovascular system
4
Susan Reed, MD, on the future of menopause research and funding
5